Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

CNY 4.76

(8.68%)

Market Cap (In CNY)

1.66 Billion

Revenue (In CNY)

1.19 Billion

Net Income (In CNY)

-605.65 Million

Avg. Volume

22.72 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.24-8.14
PE
-2.49
EPS
-1.91
Beta Value
0.056
ISIN
CNE100001XN8
CUSIP
-
CIK
-
Shares
350336000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Ming Luo
Employee Count
-
Website
https://www.chinakangyue.com
Ipo Date
2014-08-01
Details
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, designs, researches, develops, produces, and sells turbochargers in China. It offers turbocharger housing, engine exhaust manifolds, and valve body auto parts, as well as engines. The company also produces and sells solar cell module equipment and photovoltaic modules, as well as engages in the solar energy, lithium batteries, energy storage, and other energy industry businesses. Its products are used in automobiles, construction machinery, agricultural machinery, ship power, generator sets, and other industries. Kangyue Technology Co., Ltd. also exports its products to Americas, Europe, East Asia, and internationally. The company was formerly known as Kangyue Technology Co., Ltd. and changed its name to Changjiang Pharmaceutical Group Co., Ltd. in March 2023. Changjiang Pharmaceutical Group Co., Ltd. was founded in 1963 and is based in Shouguang, China.